Company intelligence / Profile preview

1778 LivingTech

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

1778 LivingTech is a biotechnology company focused on the research and development of longevity science and anti-aging solutions. Based in Beijing, the company integrates advanced life science research with consumer health products, specifically focusing on NAD+ boosters and sirtuin activators. Their business model encompasses the entire value chain from raw material synthesis to the formulation of high-end nutritional supplements. 1778 LivingTech aims to translate cutting-edge aging research into accessible health interventions to extend human healthspan.

Therapeutic areas: NeurologyMetabolic DisordersOther
Modalities: Small moleculePeptidesNatural products
Industry: Biotech

Beyond the preview

Go deeper on 1778 LivingTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1778 LivingTech.

Explore the full profile